Truveris Secures $25M in Series D Funding

Truveris, a NYC-based healthcare technology company, secured $25m in a Series D funding.

The round was led by McKesson Ventures, with participation from Canaan Partners, New Leaf Venture Partners, Tribeca Venture Partners, and New Atlantic Ventures.

The company intends to use the funds to accelerate its growth strategies.

Led by Faisal Mushtaq, President and CEO, Truveris provides cloud-based data analytics solutions for the $450 billion prescription benefits industry. The company’s technology platform aggregates data and insights from across the pharmacy ecosystem to deliver cost savings as well as patient access and affordability solutions for employers, unions, government entities, pharmaceutical manufactures, retail pharmacies and consumers.
The company works with more than 350 customers including nearly 30 labor unions, supports more than 25 pharmaceutical brands with designing, executing and monitoring integrated patient access strategies that address market dynamics, as well as large retail pharmacies to improve savings opportunities for cash paying patients.
Its consumer app, OneRx, allows both insured and uninsured users to instantly research drug and pharmacy prices to identify the drug offering and the best value to meet their medical needs.



Join the discussion